Cargando…

Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients

OBJECTIVES: To investigate the potential value of a contrast enhanced computed tomography (CECT)-based radiological-radiomics nomogram combining a lymph node (LN) radiomics signature and LNs’ radiological features for preoperative detection of LN metastasis in patients with pancreatic ductal adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qian, Song, Zuhua, Zhang, Dan, Li, Xiaojiao, Liu, Qian, Yu, Jiayi, Li, Zongwen, Zhang, Jiayan, Ren, Xiaofang, Wen, Youjia, Tang, Zhuoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579427/
https://www.ncbi.nlm.nih.gov/pubmed/36276058
http://dx.doi.org/10.3389/fonc.2022.992906
_version_ 1784812179570032640
author Li, Qian
Song, Zuhua
Zhang, Dan
Li, Xiaojiao
Liu, Qian
Yu, Jiayi
Li, Zongwen
Zhang, Jiayan
Ren, Xiaofang
Wen, Youjia
Tang, Zhuoyue
author_facet Li, Qian
Song, Zuhua
Zhang, Dan
Li, Xiaojiao
Liu, Qian
Yu, Jiayi
Li, Zongwen
Zhang, Jiayan
Ren, Xiaofang
Wen, Youjia
Tang, Zhuoyue
author_sort Li, Qian
collection PubMed
description OBJECTIVES: To investigate the potential value of a contrast enhanced computed tomography (CECT)-based radiological-radiomics nomogram combining a lymph node (LN) radiomics signature and LNs’ radiological features for preoperative detection of LN metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: In this retrospective study, 196 LNs in 61 PDAC patients were enrolled and divided into the training (137 LNs) and validation (59 LNs) cohorts. Radiomic features were extracted from portal venous phase images of LNs. The least absolute shrinkage and selection operator (LASSO) regression algorithm with 10-fold cross-validation was used to select optimal features to determine the radiomics score (Rad-score). The radiological-radiomics nomogram was developed by using significant predictors of LN metastasis by multivariate logistic regression (LR) analysis in the training cohort and validated in the validation cohort independently. Its diagnostic performance was assessed by receiver operating characteristic curve (ROC), decision curve (DCA) and calibration curve analyses. RESULTS: The radiological model, including LN size, and margin and enhancement pattern (three significant predictors), exhibited areas under the curves (AUCs) of 0.831 and 0.756 in the training and validation cohorts, respectively. Nine radiomic features were used to construct a radiomics model, which showed AUCs of 0.879 and 0.804 in the training and validation cohorts, respectively. The radiological-radiomics nomogram, which incorporated the LN Rad-score and the three LNs’ radiological features, performed better than the Rad-score and radiological models individually, with AUCs of 0.937 and 0.851 in the training and validation cohorts, respectively. Calibration curve analysis and DCA revealed that the radiological-radiomics nomogram showed satisfactory consistency and the highest net benefit for preoperative diagnosis of LN metastasis. CONCLUSIONS: The CT-based LN radiological-radiomics nomogram may serve as a valid and convenient computer-aided tool for personalized risk assessment of LN metastasis and help clinicians make appropriate clinical decisions for PADC patients.
format Online
Article
Text
id pubmed-9579427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95794272022-10-20 Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients Li, Qian Song, Zuhua Zhang, Dan Li, Xiaojiao Liu, Qian Yu, Jiayi Li, Zongwen Zhang, Jiayan Ren, Xiaofang Wen, Youjia Tang, Zhuoyue Front Oncol Oncology OBJECTIVES: To investigate the potential value of a contrast enhanced computed tomography (CECT)-based radiological-radiomics nomogram combining a lymph node (LN) radiomics signature and LNs’ radiological features for preoperative detection of LN metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: In this retrospective study, 196 LNs in 61 PDAC patients were enrolled and divided into the training (137 LNs) and validation (59 LNs) cohorts. Radiomic features were extracted from portal venous phase images of LNs. The least absolute shrinkage and selection operator (LASSO) regression algorithm with 10-fold cross-validation was used to select optimal features to determine the radiomics score (Rad-score). The radiological-radiomics nomogram was developed by using significant predictors of LN metastasis by multivariate logistic regression (LR) analysis in the training cohort and validated in the validation cohort independently. Its diagnostic performance was assessed by receiver operating characteristic curve (ROC), decision curve (DCA) and calibration curve analyses. RESULTS: The radiological model, including LN size, and margin and enhancement pattern (three significant predictors), exhibited areas under the curves (AUCs) of 0.831 and 0.756 in the training and validation cohorts, respectively. Nine radiomic features were used to construct a radiomics model, which showed AUCs of 0.879 and 0.804 in the training and validation cohorts, respectively. The radiological-radiomics nomogram, which incorporated the LN Rad-score and the three LNs’ radiological features, performed better than the Rad-score and radiological models individually, with AUCs of 0.937 and 0.851 in the training and validation cohorts, respectively. Calibration curve analysis and DCA revealed that the radiological-radiomics nomogram showed satisfactory consistency and the highest net benefit for preoperative diagnosis of LN metastasis. CONCLUSIONS: The CT-based LN radiological-radiomics nomogram may serve as a valid and convenient computer-aided tool for personalized risk assessment of LN metastasis and help clinicians make appropriate clinical decisions for PADC patients. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9579427/ /pubmed/36276058 http://dx.doi.org/10.3389/fonc.2022.992906 Text en Copyright © 2022 Li, Song, Zhang, Li, Liu, Yu, Li, Zhang, Ren, Wen and Tang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Qian
Song, Zuhua
Zhang, Dan
Li, Xiaojiao
Liu, Qian
Yu, Jiayi
Li, Zongwen
Zhang, Jiayan
Ren, Xiaofang
Wen, Youjia
Tang, Zhuoyue
Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title_full Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title_fullStr Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title_full_unstemmed Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title_short Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients
title_sort feasibility of a ct-based lymph node radiomics nomogram in detecting lymph node metastasis in pdac patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579427/
https://www.ncbi.nlm.nih.gov/pubmed/36276058
http://dx.doi.org/10.3389/fonc.2022.992906
work_keys_str_mv AT liqian feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT songzuhua feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT zhangdan feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT lixiaojiao feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT liuqian feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT yujiayi feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT lizongwen feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT zhangjiayan feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT renxiaofang feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT wenyoujia feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients
AT tangzhuoyue feasibilityofactbasedlymphnoderadiomicsnomogramindetectinglymphnodemetastasisinpdacpatients